Category: Illness or disabilities
Introduction and description
Streptococcus is a genus of coccus (spherical) gram-positive bacteria belonging to the phylum Firmicutes and the Lactobacillales (lactic acid bacteria) order.
Currently, over 50 species are recognised in this genus, although there has been some reordering of the bacteria so that, for example, in 1984, many organisms formerly considered Streptococcus were separated out into the genera Enterococcus and Lactococcus.
They can cause extremely serious disease. Globally, group A Streptococcus (GAS), has been estimated to cause more than 500,000 deaths every year, making it one of the world's leading pathogens.
The Alpha and Beta haemolytic division
The following is complex, but it needs to be explained as there are important implications within the description. Species of Streptococcus are classified based on their hemolytic properties. The division is:
Gamma-hemolytic species cause no hemolysis.
Alpha-hemolytic species cause oxidization of iron in hemoglobin molecules within red blood cells. Thus there are links here to anaemia.
Beta-hemolytic species cause complete rupture of red blood cells. Streptolysin, an exotoxin, is the enzyme produced by the bacteria which causes the complete lysis of red blood cells. There are two types of streptolysin:
- Streptolysin O (SLO) - Streptolysin O is an oxygen-sensitive cytotoxin, secreted by most Group A streptococcus (GAS), and interacts with cholesterol in the membrane of eukaryotic cells (mainly red and white blood cells, macrophages, and platelets), and usually results in β-hemolysis under the surface of blood agar. In this case anything – that is pharmaceutical - which interferes with the supply of cholesterol is going to make recovery very difficult
- Streptolysin S (SLS) - Streptolysin S is an oxygen-stable cytotoxin also produced by most GAS strains which results in clearing on the surface of blood agar. SLS affects immune cells, including polymorphonuclear leukocytes and lymphocytes, and is thought to prevent the host immune system from clearing infection. Streptococcus pyogenes, or Group A beta-hemolytic Strep (GAS), displays beta hemolysis. Thus anything – that is pharmaceutical - which further prevents the immune system from recovering and trying to stage a come-back is also going to make recovery very difficult
So statins and immunosuppressants are going to be very unhelpful, for example. Beta-hemolytic streptococci are further classified by Lancefield grouping, a serotype classification. The 20 described serotypes are named Lancefield groups A to V (excluding I and J).
‘Good’ bacteria and ‘bad’ bacteria
Although they are grouped and named according to their physical characteristics - cellular division occurs along a single axis in these bacteria, and thus they grow in chains or pairs, hence the name from Greek στρεπτός streptos, meaning easily bent or twisted, like a chain (twisted chain) – they are functionally an extremely diverse group.
Some are pathogenic and some are not, some can turn pathogenic, thus the grouping includes:
- Good - bacteria that are actually necessary and helpful to us forming part of the commensal human microbiota of the mouth, skin, intestine, and upper respiratory tract;
- Neutral - bacteria that are harmless to us, for example, streptococci are a necessary ingredient in producing Emmentaler ("Swiss") cheese; and
- Bad - bacteria that cause very serious illness and disease - certain Streptococcus species are, at first glance, responsible for many cases of pink eye, meningitis, bacterial pneumonia, endocarditis, erysipelas, and necrotizing fasciitis (the 'flesh-eating' bacterial infections).
One of the strangest aspects of many species of Streptococcus is that they are the victims of Bacteriophage. A bacteriophage is a virus that infects and replicates within a bacterium. The term is derived from "bacteria" and the Greek: φαγεῖν (phagein), "to devour". Except the name isn't technically correct, they tend not to kill their host. Bacteriophages are composed of proteins that encapsulate a DNA or RNA genome.
Phages may be released via cell lysis, by extrusion, or, in a few cases, by budding. Lysis, by tailed phages, is achieved by an enzyme called endolysin, which attacks and breaks down the cell wall peptidoglycan. An altogether different phage type, the filamentous phages, make the host cell continually secrete new virus particles. Released virions are described as free, and, unless defective, are capable of infecting a new bacterium. Budding is associated with certain Mycoplasma phages. In contrast to virion release, phages displaying a lysogenic cycle do not kill the host but, rather, become long-term residents as prophage.
The Streptococcus phages have not yet been investigated systematically or fully.
At the moment there are a number of still unanswered questions related to streptococci bacteria. The first question relates, in some cases to exactly how they work, the second relates to why they are sometimes virulent and destructive and sometimes not.
And there is some [justified] speculation that it is not the bacteria that is destructive but the viruses they unwittingly host.
The destructive nature of virus phages in nature in general,, is already known, the research questions still to be tackled are how does this apply to Streptococcus? For example:
Disease is an increasing threat to reef-building corals. One of the few identified pathogens of coral disease is the bacterium Vibrio coralliilyticus. In Vibrio cholerae, infection by a bacterial virus (bacteriophage) results in the conversion of non-pathogenic strains to pathogenic strains and this can lead to cholera pandemics. PMID: 26644037
Diseases caused by streptococci
The following table from Wikipedia is a summary of some of the diseases caused by the ‘bad’ bacteria and/or good turned bad. More details are given below
Table: Medically relevant streptococci – source Wikipedia
neonatal meningitis and sepsis
endocarditis, bacteremia, pneumonia, meningitis, respiratory infections
biliary or urinary tract infections, endocarditis
subcutaneous/organ abscesses, meningitis, respiratory infections
endocarditis, dental caries
bacterial pneumonia and occasional etiology of otitis media, sinusitis, meningitis, and peritonitis.
Using the research papers described on this site, however, quite a long list of other diseases are linked to this bacteria [or possibly the phages of this bacteria]:
Some of the species in more detail
S. pyogenes, also known as Group A Streptococcus (GAS), is the causative agent in a wide range of group A streptococcal infections. They include streptococcal pharyngitis (strep throat), impetigo and scarlet fever.
Some infections caused by group A β-hemolytic streptococci can be more severe. When the bacterium is able to infect the blood and internal organs, the diseases that may be caused include streptococcal toxic shock, necrotizing fasciitis, pneumonia, and bacteremia.
Group A Streptococcus can also cause acute rheumatic fever and acute glomerulonephritis. Rheumatic fever is a consequence of untreated strep A infection caused not by the bacterium itself. So here we have an instance where the phages may be the root cause.
Streptococcus agalactiae is a gram-positive, beta-hemolytic bacteria. It is the species designation for streptococci belonging to the group B of the Rebecca Lancefield classification – hence the name Group B Streptococcus – or GBS. In general, it is a harmless commensal bacterium being part of the human microbiota colonizing the gastrointestinal and genitourinary tract of up to 30% [possibly more] of healthy human adults.
Although GBS colonization generally does not cause problems in women during pregnancy, it can sometimes cause serious illness for the mother and baby during gestation and after delivery. GBS infections in the mother can cause chorioamnionitis (a severe infection of the placental tissues) and postpartum infections (after birth). GBS urinary tract infections (UTI) may induce labour and cause premature delivery. GBS infections in newborns are separated into two clinical syndromes, early-onset disease (EOD) and late-onset disease (LOD).
- EOD - manifests from 0 to 7 living days in the newborn, most of the cases of EOD being apparent within 24h of birth. The most common clinical symptoms of EOD are sepsis, pneumonia, and less frequently meningitis. EOD is acquired through exposure of the fetus or the baby to GBS from the vagina of a colonized woman, either intrautero or during birth after rupture of membranes. Roughly 50% of newborns to GBS colonized mothers are also GBS colonized but only 1–2% of these newborns will develop EOD.
- LOD affects infants from 7 days to 3 months of age and is more likely to cause bacteremia or meningitis. LOD can be acquired from the mother or from environmental sources. Hearing loss and mental impairment can be a long-term sequela of GBS meningitis. In contrast with EOD, the incidence of LOD has remained unchanged at 0.26 per 1000 live births in the US. S. agalactiae neonatal meningitis does not present with the hallmark sign of adult meningitis, a stiff neck; rather, it presents with nonspecific symptoms, such as fever, vomiting and irritability, and can consequently lead to a late diagnosis
So, why only some? Why the different symptoms? And again the answer may be that it is not the bacteria that is the culprit, but the viruses it is hosting – the phages.
Theviridans streptococci are most abundant in the mouth, and one member of the group, S. mutans, is the etiologic agent of dental caries in most cases and populations. S. sanguinis is also another potential cause. Others may be involved in other mouth or gingival infections as pericoronitis.
If they are introduced into the bloodstream, they have the potential of causing endocarditis, in particular in individuals with damaged heart valves. They are the most common causes of subacute bacterial endocarditis.
Viridans streptococci have the unique ability to synthesize dextrans from glucose, which allows them to adhere to fibrin-platelet aggregates at damaged heart valves. This mechanism underlies their ability to cause subacute valvular heart disease following their introduction into the bloodstream (e.g., following dental extraction).
But it doesn't happen all the time, otherwise everyone with tooth decay and bleeding gums would have heart disease.
So, why only some? And again the answer may be that it is not the bacteria that is the culprit, but the viruses it is hosting – the phages.
Streptococcus tigurinus is generally not a normal part of the human bacteria flora and it is currently unknown where its natural habitat is or its potential for colonization. Capable of causing serious infections if it manages to enter the body's bloodstream, usually through open wounds, it was first discovered to cause invasive infections after it was isolated from a patient with infective endocarditis. It was later detected in the blood and cerebrospinal fluid of 14 other patients with varying types of serious invasive infections such as spondylodiscitis, bacteremia, meningitis, and empyema.
And so we could continue, but we hope the pattern is clear. From different strains of these bacteria, similar illnesses emerge, but only in some people. Clearly anybody who is immunocompromised is going to fare worse, but there is also the indication that it could be exactly the same viruses causing these disease, but using different hosts to do so – different bacterial strains.
The medical community use antibiotics, but the bacteria are becoming resistant to many antibiotics as a consequence of the serious misapplication of these drugs.
There is the possibility that by killing the host bacteria one does indeed kill the viruses they are hosting – but are we sure? These viruses – the phages - are extremely tiny and many researchers are not looking for them, but are only looking for the bacteria, as such we may be missing a great deal. Can these tiny viruses live without their host bacteria once they have infected a cell?
If the paper cited below is representative [Virus evolution toward limited dependence on nonessential functions of the host: the case of bacteriophage SPP1.], the answer is yes. In other words, the virus is actually able to survive on its own once it is in the host. The bacteria is used to get in and then to multiply, a sort of safe nest for baby phages.
We have provided a list from Dr Duke’s phytochemical database of plants that have been shown to have antistreptococcic activity. His list is, however, based on the list of chemicals in the plants shown to have this activity. It may be that this approach is no better than the approach that uses antibiotics, however, the plants at least generally do no harm.
Dr Duke’s list of Chemicals with Antistreptococcic Activity
AGROPYRENE MIC=200->200 ug/ml
ARBUTIN MIC=4,000-8,000 ppm
BAKUCHIOL 20 ug/ml
ELLAGIC-ACID ID50=20 ug/ml
MENTHOL MIC=0.4 mg/ml
QUERCETIN ID50=120 ug/ml
THYMOHYDROQUINONE MIC=200-400 ug/ml
THYMOL MIC=200-400 ug/ml
Fri Oct 30 16:58:43 EDT 2015
References and further reading
J Virol. 2015 Mar;89(5):2875-83. doi: 10.1128/JVI.03540-14. Epub 2014 Dec 24. Virus evolution toward limited dependence on nonessential functions of the host: the case of bacteriophage SPP1. Cvirkaite-Krupovic V1, Carballido-López R2, Tavares P1.
1Unité de Virologie Moléculaire et Structurale, CNRS UPR3296, Centre de Recherche de Gif, Gif-sur-Yvette, France firstname.lastname@example.org email@example.com.
2INRA, UMR1319 Micalis, Jouy-en-Josas, France AgroParisTech, UMR1319 Micalis, Jouy-en-Josas, France
- Action of essential oils from Brazilian native and exotic medicinal species on oral biofilms 020548
- Antimicrobial activity of extracts of local cough mixtures on upper respiratory tract bacterial pathogens 021235
- Antimicrobial activity of natural products from the flora of Northern Ontario, Canada 019569
- Carum copticum L.: A Herbal Medicine with Various Pharmacological Effects - Antimicrobial effects 027884
- Dr Duke's list of Plants with Antistreptococcic Activity 018392
- Dr Duke’s list of Antibacterial Activities in: Ailanthus altissima -- Stinktree, Tree Of Heaven 018310
- Dr Duke’s list of Ethnobotanical uses for Gliricidia sepium (Fabaceae) 021426
- Effect of Honey and Green Tea Solutions on Streptococcus mutans 020931
- Gentian Violet: A 19th Century Drug Re-Emerges in the 21st Century 026150
- Herbs and Streptococcus pyogenes 010326
- In vitro antimicrobial activity of Luffa operculata 019900
- Kaffir lime leaves extract inhibits biofilm formation by Streptococcus mutans 021220
- New Phytochemical Constituent and Bioactivities of Horwoodia dicksoniae and Rumex cyprius 023030
- Plants used to treat skin diseases 027515
- Pyrano-isoflavans from Glycyrrhiza uralensis with antibacterial activity against Streptococcus mutans and Porphyromonas gingivalis 019316
- Spices herbs and bacteria 005424
- Stephen Harrod Buhner - Herbal Antivirals - Ginger 017501
- Summary of Dr Duke’s analysis showing the Antipathogenic Activities in: Azadirachta indica -- Neem 018320
- The Healing Power of Sleep 026790
- Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis 019060
- E-mycin 018946
- Erymax 018959
- Erythromycin 018962
- Genetic association, seasonal infections and autoimmune basis of narcolepsy 019059
- Narcolepsy during Childhood: An Update 019057
- Respiratory infections: clinical experiences with the new quinolones 019058
- The quinolones in chronic bronchitis 020263